The Anti-Coagulation Video Channel* is intended for primary care practitioners and specialists involved in the treatment and follow up care of patients with atrial fibrillation (AF) or venous thromboembolism (VTE). It provides an overview of how to prevent stroke and systemic embolism in nonvalvular AF patients and how to prevent and treat VTE.
Users can expect to find the following videos readily available on the video channel with regular updates:
The benefits of dabigatran in preventing stroke in atrial fibrillation patients (Hans-Christoph Diener, Gregory YH Lip and John Eikelboom)
Dabigatran for the treatment and prevention of DVT and PE (Samuel Z Goldhaber)
The safety profile of dabigatran (Hans-Christoph Diener, John Eikelboom and Jeffrey Weitz)
Healthcare professionals should return often to avoid missing out on new content.
*The Anti-Coagulation Video Channel has been supported by an educational grant from Boehringer Ingelheim, who provided the videos, and is intended for healthcare professionals outside the USA, Canada and UK.
The Thrombosis Educational Portal is intended for healthcare professionals involved in the treatment and management of venous and arterial thrombosis. This resource is organised around the following sections:
Acute Coronary Syndrome (ACS)
Users will also have access to a newsletters section, which is updated on a quarterly basis with related thrombosis news content. The most recent edition from February 2015 contains an article written by Professor John Camm, Professor of Clinical Cardiology at St George’s, University of London and Imperial College London titled ‘Extending the Clinical Utility of Novel Oral Anticoagulants’.
This resource is intended to provide information to an international audience outside of the UK and the USA.
The Obesity Learning Hub contains clinical information and resources for healthcare professionals involved in the treatment and management of obese or overweight patients.
Here you will find a Knowledge Centre with information on epidemiology, pathophysiology, clinical guidelines, assessment and treatment options, prevention methods and more. Other sections within the Learning Hub include a clinical media library, news and journal articles, events information, patient guides and the EACCME-accredited European Obesity Initiative CME series, which is worth five European CME Credits (ECMECs) in total.
This educational resource contains a range of content developed for healthcare professionals based in Europe who are involved in the treatment and management of type 2 diabetes mellitus. In this section you will find:
This EACCME-accredited obesity CME series contains three CME modules, which are ideal for healthcare professionals looking to improve their understanding of obesity as a serious medical illness.
Module 1 – Understanding Obesity
Learn more about obesity as a serious and complex medical illness including comorbidities and complications, the complex factors that influence its development and the cornerstones of an effective weight-management strategy.
Module 3 – Rationale for Lifelong Behaviour Change
Explore the factors affecting maintenance of weight loss, the importance of implementing permanent behaviour changes to prevent weight regain and the components of a successful long-term weight-management strategy.
Christopher D. Pfeiffer, Clinical Fellow, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA Vance Fowler, Associate Professor and Infectious Diseases, Specialist, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
Case History A 64-year-old female presented with three weeks of progressive dyspnoea, nausea and vomiting.
Would you consider recommending garlic tablets for patients with hypertension? Either instead of initiating monotherapy, or as an adjunct to current medication if they remained poorly controlled? The evidence for benefit is growing…
Infective endocarditis (IE) is a deadly disease. Despite improvements in its management, IE..
... remains associated with high mortality and severe complications. Until recently, guidelines on IE were mostly based on expert opinion because of the low incidence of the disease, the absence of randomized trials and the limited number of meta-analyses.
The 2009 ESC Guidelines on the prevention, diagnosis and treatment of IE8 introduced several innovative concepts, including limitation of antibiotic prophylaxis to the highest-risk patients, a focus on healthcare-associated IE and identification of the optimal timing for surgery. However, several reasons justify the decision of the ESC to update the previous guidelines: the publication of new large series of IE, including the first randomized study regarding surgical therapy; important improvements in imaging procedures, particularly in the field of nuclear imaging; and discrepancies between previous guidelines. In addition, the need for a collaborative approach involving primary care physicians, cardiologists, surgeons, microbiologists, infectious disease (ID) specialists and frequently other specialists— namely the ‘Endocarditis Team’—has been underlined recently and will be developed in these new guidelines.
The main objective of the current Task Forcewas to provide clear and simple recommendations, assisting healthcare providers in their clinical decision making. These recommendations were obtained by expert consensus after thorough review of the available literature. An evidence-based scoring system was used, based on a classification of the strength of recommendations and the levels of evidence.
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple clinical..
... conditions and can complicate the majority of cardiovascular and respiratory diseases. The composition of the guidelines task force reflects themultidisciplinary nature of PH, including members of different medical societies, associations and working groups. The current document follows the two previous ESC and ERS Guidelines, published in 2004 and 2009, focusing on clinical management of PH. A systematic literature review was performed from MEDLINEw to identify new studies published since 2009 concerning the topic of PH. Task force members selected studies based on relevance and appropriateness.
Learn more about obesity as a serious and complex medical illness including comorbidities and complications, the complex factors that influence its development and the cornerstones of an effective weight-management strategy....
Explore the factors affecting maintenance of weight loss, the importance of implementing permanent behaviour changes to prevent weight regain and the components of a successful long-term weight-management strategy. EACCME accredited.
Abdominal obesity is a major risk factor for heart attack, stroke, peripheral vascular disease, dementia, cancer and Type 2 diabetes. The central hypothesis for this proposal is that pro-atherogenic ...